REQUEST A DEMO
Total
USD $0.00
Search more companies

Naturland Holding Zrt (Hungary)

Main Activities: Real Estate Property Managers
Full name: Naturland Holding Zrt Profile Updated: October 02, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Hungarian Download a sample report

Naturland Holding zrt. was founded in April 06, 2012 by Mr. Emil Szanto and Mr. Zoltan Tibor Asvanyi. As the founding owner, Naturland Holding Plc. - an asset management company - manages the strategic operations of its wholly owned subsidiary company, Naturland Hungary Ltd. The company is proud of its medium-sized pharmaceutical manufacturing culture in Hungary and its products which combine science with tradition. The Naturland brand is present in the most important part of people s life: in health and healthcare. An essential element of self-care and disease prevention is trust. During the production of its products, Naturland puts a significant emphasis on maintaining the well-established trust and the recognition of its brand. Naturland carries out full scale pharmaceutical manufacturing activities, ranging from research and development, through product licensing and production, to an independent pharmaceutical wholesale activity. For the production of its ointments, solutions, tablets, suppositories, ophthalmic stock solutions and for the packaging of pharmaceutical raw materials, the company has pharmaceutical manufacturing licenses and a license for the independent wholesale of pharmaceuticals and medicinal products. In addition to pharmacies - serviced and supplied by Naturland s own sales representatives and delivery fleet - the company s products are also delivered to drugstores, independent herbal stores and domestic, international FMCG retail partners. The company s three decades of accumulated knowledge in development and production of more than 400 registered medicines, pharmaceutical ingredients, dietary supplements, cosmetics, and tea variations are made available to its domestic and international pharmaceutical partners through its contract manufacturing services. The fundamental strategic goal of the company is autonomy and independence, which ensures a high degree of adaptability and flexibility to maintain its ability to quickly respond to the ever-changing market environment.
The company was listed on HUF since Sep 09, 2022 under symbol NATURLAND

Headquarters
1106 Budapest, Csillagvirag Utca 8
Budapest; Budapest; Postal Code: 1074

Contact Details: Purchase the Naturland Holding Zrt report to view the information.

Website: http://www.naturlandholding.hu

Basic Information
Outstanding Shares:
Purchase the Naturland Holding Zrt report to view the information.
Financial Auditors:
Purchase the Naturland Holding Zrt report to view the information.
Incorporation Date:
2012
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Naturland Hungary Kft.
100%
Naturland Magyarorszag Kft
100%
Company Performance
Financial values in the chart are available after Naturland Holding Zrt report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
11.25%
Total operating revenue
10.38%
Operating profit (EBIT)
22.19%
EBITDA
11.53%
Net Profit (Loss) for the Period
22.18%
Total assets
1.97%
Total equity
8.09%
Operating Profit Margin (ROS)
2.09%
Net Profit Margin
2.03%
Return on Equity (ROE)
2.74%
Debt to Equity Ratio
-1.38%
Quick Ratio
0.43%
Cash Ratio
0.43%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?